Mast cell activation by group A streptococcal polysaccharide in the rat and its role in experimental arthritis. by Dalldorf, Frederic G. et al.
American Journal of Pathology, Vol. 132, No. 2, August 1988
Copyright © American Association of Pathologists
Mast Cell Activation by Group A Streptococcal
Polysaccharide in the Rat and Its Role in
Experimental Arthritis
FREDERIC G. DALLDORF, MD,
SONYA K. ANDERLE, MS,
ROGER R. BROWN, BSc, and
JOHN H. SCHWAB, PhD
Acute edematous responses were induced in Sprague-
Dawley rats by the intravenous injection ofgroup-spe-
cific polysaccharide (PS) isolated from group A strep-
tococci. Thirty minutes after the intravenous injection
ofPS there was marked degranulation ofsubcutaneous
and periarticular mast cells in all 4 feet, carbon particle
labeling of adjacent venules, and an 8-fold increase in
Evans blue dye content of the extremities. This acute
INTRAPERITONEAL INJECTION of Sprague-
Dawley rats with a sterile aqueous suspension of pep-
tidoglycan-polysaccharide fragments (PG-PS) from
Group A streptococci induces a prolonged inflamma-
tory polyarthritis.' Most ofthe PG-PS accumulates in
the liver, spleen, and lymph nodes, where it causes
acute inflammation but only moderate chronic dis-
ease in this outbred strain of rat. A small amount of
the material accumulates about the joints of all 4 ex-
tremities, where it elicits an acute diffuse polyarticular
arthritis that starts as a focal vasculitis and synovitis
16 hours after injection, peaks 3 days later, and then
recedes. This is followed by chronic relapsing polyar-
ticular arthritis that leads to pannus formation, de-
struction of articular cartilage, and ankylosis. '2 The
localization ofthe PG-PS within the reticuloendothel-
ium of the rat is understandable as the material
quickly gains access to circulating leucocytes and
plasma via the peritoneal lymphatics, but the mecha-
nism for its selective deposition in and about thejoints
is still unknown. Morphologic studies demonstrated
early localization of cell wall material within neutro-
philes passing through venule walls in the synovium
16 hours into the reaction but failed to explain this
From the Departments ofPathology and Microbiology and
Immunology, School ofMedicine, University ofNorth Carolina,
Chapel Hill, North Carolina
reaction to PS was completely blocked by pretreat-
ment with compound 48/80, but the polyarticular re-
lapsing arthritis following the systemic injection ofan
arthropathic dose of streptococcal cell wall fragments
containing large, covalently bound peptidoglycan-
polysaccharide (PG-PS) was not blocked. (AmJ Pathol
1988, 132:258-264)
selective vascular response.2 Recently Chetty, Brown,
and Schwab3 reported that purified group-specific
polysaccharide (PS) isolated from group A streptococ-
cal cell wall fragments, when injected intravenously,
causes transient acute edema largely confined to the
limbs. Because the PG-PS preparations contain some
free PS together with the cell wall fragments it was sug-
gested that an acute vascular reaction to small
amounts ofPS might predispose the extremities to the
deposition ofPG-PS and the later development of ar-
thritis.3 This concept was further supported by the ob-
servation that more purified preparations of PG-PS
produced little arthritis in Sprague-Dawley rats unless
PS was added to the intraperitoneal innoculum.3 The
purpose ofthis study is to investigate the pathogenesis
ofthe edema-producing properties ofPS in the rat and
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Fragments and Group-Specific Cell Wall
Polysaccharide
Group A, type 3, strain D-58 streptococci were
grown in Todd-Hewitt broth, harvested, washed, and
disrupted in a Braun MSK shaker (Braun Instru-
ments, San Francisco, CA) and the cell wall fragments
purified by differential centrifugation and enzyme
treatment, as described previously.4 The group-spe-
cific polysaccharide was isolated from the cell walls by
the method of Krause5 as modified by Chetty, Klap-
per, and Schwab.4 A cell wall preparation was sus-
pended in formamide (5 mg/ml) and extraction was
performed at 150 C for 20 minutes. After being cooled
overnight at 4 C, the extracted preparation was centri-
fuged (36,000g, 30 minutes, 4 C), the supernatant was
mixed with 2 volumes of acid-alcohol (95% ethanol
and 5% 1 N HCl), and the mixture was centrifuged
(12,000g, 30 minutes, 4 C). The PS in the alcoholic
supernatant was precipitated by adding 5 volumes of
acid-acetone (99% acetone and 1% HCl) and a few
crystals ofsodium acetate to the supernatant. This was
held at 4 C for 72 hours. The acid-acetone precipitable
carbohydrate was dissolved in distilled water, clarified
by centrifugation, and treated with acid-alcohol and
acid-acetone once more. The PS obtained from the
second acid-acetone treatment was suspended in dis-
tilled water, dialyzed against distilled water for 48
hours at 4 C, and passed through Dowex-50 X 8 (200-
400 mech) cation exchange resin (Bio-Rad Labora-
tories, Richmond, CA) before lyophilization. The ly-
ophilized PS was suspended in an appropriate
amount of distilled water and was treated again with
acid-alcohol and acid-acetone before use. The rham-
nose concentration was determined on each batch by
the method of Dische and Shettles.6
Animals
Outbred female Sprague-Dawley rats were pur-
chased from Zivic-Miller Laboratories, Allison Park,
PA, and weighed 120-160 gms at the beginning ofthe
experiments.
Histologic Methods
Rats were killed by ether overdose and complete au-
topsies performed. Tissues were fixed in 10% phos-
phate buffered formalin and in selective experiments
sections prepared from the skin, snout, ears, tail,
lungs, gut, liver, spleen, mediastinal lymph nodes,
thymus, kidneys, and the left front and rear feet. The
feet were decalcified with formic acid sodium citrate
solution and sectioned longitudinally with the skin.
All histologic sections were stained with toluidine blue
and some with hematoxylin and eosin (H&E) and pe-
riodic acid-Schiffdigest.
Morphologic Studies
Fourteen rats were injected intravenously with 6 .g
PS/g body weight in PBS. Seven of these were sacri-
ficed after 30 minutes and 7 after 6 hours. Three ofthe
30-minute rats were also injected intravenously with 1
ml of a 5% suspension of India ink (Higgins Drawing
Ink) in PBS 25 minutes before sacrifice. Two adli-
tional control rats received PBS intravenously 30
minutes before sacrifice and 1 of these was also in-
jected with India ink 25 minutes before sacrifice.
Three ofthe 7 rats held 6 hours after PS injection were
also injected with India ink 25 minutes before sacri-
fice. Two additional control rats were injected with
PBS and sacrificed after 6 hours. One ofthese controls
was also injected with India ink 25 minutes before sac-
rifice. All but 1 of the 14 rats receiving PS developed
gross edema of all 4 feet. The edema had subsided
completely in the rats held 6 hours. None ofthe 4 con-
trol rats injected with PBS developed edema.
Measurement of Permeability Response
The method of Udaka, Takeuchi, and Movat7 was
used. Each rat received 6.5 mg filtered Evans blue in
PBS intravenously 45 minutes before sacrifice. The
right hind and fore feet were removed 2 mm above
the ankle from each rat, frozen in liquid nitrogen, pul-
verized and the dye extracted with PBS. The optical
density was measured in a spectrophotometer at 620
mu and the quantity ofdye per combined sample cal-
culated using a standard dye dilution curve.
Compound 48/80 Degranulation of Mast Cells
The method used was a modification of that of
Riley and West.8 Treated rats received increasing in-
traperitoneal doses of 48/80 for 5 days. On the first
day each rat received 100 ,ug intraperineally in the af-
ternoon. On the second day they received 200 ,ug
twice, once in the morning and once in the afternoon,
on the third day 300 ,g twice, and on the fourth day
400 ,g twice. The fifth day the rats were injected once
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Figure 1-PS-induced edema. The rat on the left was injected intravenously
with 6 ,g PS/g body weight 30 minutes before they were killed. The rat on
the right was the PBS control. Note marked foot swelling on the left.
in the morning with 500 ,ug and experiments were per-
formed on the morning of the sixth day. All rats be-
came short of breath and had edema of their feet and
nose following each injection. Using this modified
schedule none of the rats died and they all gained
weight, as did controls. Control rats were injected
twice a day with a comparable volume ofPBS.
Compound 48/80 Inhibition of PS-Induced Edema
Twenty rats were divided into 3 groups. In Group
I, 6 rats were injected intraperineally with graded
doses of48/80 for 5 days. On day 6 they were injected
IV with 6.5 mg Evans blue in PBS 45 minutes before
sacrifice and PBS alone intravenously 30 minutes be-
fore sacrifice. In Group II, 7 rats were injected intra-
perineally with graded doses of 48/80 for 5 days. On
day 6 they were injected intravenously with 6.5 mgm
Evans blue in PBS 45 minutes before sacrifice and 6
,ug PS/g body weight 30 minutes before sacrifice. In
Group III, 7 rats were injected intraperineally for 4
days with PBS. On day 6 they were injected first with
Evans blue in PBS 45 minutes before sacrifice and
then 6 ,ug PS/g body weight PS 30 minutes before sac-
rifice. All rats were injected intravenously through the
tail veins under light ether anesthesia and were killed
with ether. Observations were made of the gross ap-
pearance of all rats. The left front and rear feet were
prepared for histology and sections stained with tolu-
idine blue. The right feet were excised 2 mm proximal
to the wrist or ankle and analysed for total content of
Evans blue dye.
Compound 48/80 and Experimental Arthritis
Thirty-four rats were divided into 3 groups. Four-
teen rats in Group 1 were injected twice a day for 5
days with PBS and on day 6 were injected intraperi-
neally with an arthropathic dose of sonicated strepto-
coccal cell wall material (PG-PS) containing 20 ,g
rhamnose/g body weight. They were examined daily
and each joint was graded for arthritis on a scale of0-
4.' A total score for all 4 feet was recorded and means
plus S.D. calculated for the entire group. Six of these
14 rats were killed on the third day after the injection
of the PG-PS, at the height of their acute arthritis.
Their right feet and livers were assayed for content of
PG-PS.9 Their left feet, liver, and spleen were pre-
pared for histology. The remaining 8 rats were ob-
served for 40 days and killed. The right feet and livers
were analysed for PG-PS content.
Thirteen Group 2 rats were injected intraperineally
twice a day for 5 days with graded doses ofcompound
48/80. On day 6 all 13 rats received the same arthro-
pathic dose ofPG-PS intraperineally. These rats were
observed and their joints scores recorded as before.
Seven of the Group 2 rats were killed 3 days after the
PG-PS injection and their same tissues studied. The
remaining 7 rats in this group were observed for 40
more days and then killed. Their right feet were also
analysed for content of PG-PS. The 7 Group 3 rats
were used as negative controls. They received the
same injections of compound 48/80. Three were
killed on day 6 and their feet examined histologically
for the presence of granulated mast cells. The other 4
rats were injected with PBS intraperineally on day 6




Sprague-Dawley rats have many mast cells that
stain well with toluidine blue after formalin fixation.
These cells are particularly prominent in the joints,
around tendons, in the skin, ears, nose, and tail. They
are present in decreased numbers within the internal
organs. Thirty minutes after the intravenous injection
of 6 Ag (dry wt)/g body weight PS in PBS there was
marked swelling of all 4 feet in 11 of 14 rats (Figure
1). Two had slight swelling and 1 had no observable
swelling. Four control rats that were injected intrave-
nously with PBS had no swelling. The edema had
completely subsided by 6 hours in all rats held for that
time.
Toluidine blue stained sections of the feet of rats
with edema, killed at 30 minutes, contained many
mast cells that had released their granules (Figure 2).
The 2 acute test rats that had no or minimal edema
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Figure 4-Synovium from the joint of a rat injected intravenously with PS
and India Ink 30 minutes before it was killed. The venule near the center is
surrounded by dark staining mast cell granules and its wall contains several
black carbon particles (arrow). (toluidine blue, x800)
Figure 2-Mast cell release. This toluidine blue stained section of edema-
tous tissues adjacent to a joint in a rat injected 30 minutes earlier intrave-
nously with PS. Most of the dark staining mast cells are surrounded by nu-
merous released granules. (x315)
had only rare mast cells that had released their gran-
ules and appeared morphologically indistinguishable
from the PBS controls. Significant but less marked
granule release was observed in the tissues of the nose
and ears. No mast cell changes were observed in the
lungs, tail, trachea, spleen, gut, abdominal wall, or
thymus. Three ofthe rats killed 30 minutes after injec-
tion, and one acute PBS control also received a dilute
suspension of India ink 30 minutes before sacrifice.
Two of the 3 test rats that had gross edema demon-
Figure 3-Synovial tissue from the joint of a rat injected intravenously with
PS 30 minutes and India Ink 20 minutes before it was killed. The wall of
this small vein contains many black carbon particles (arrow). (Kernechtrot's
nuclear fast red, x560)
strated many venules marked with black carbon parti-
cles (Figure 3). These venules were usually adjacent to
degranulating mast cells (Figure 4). The labeled ves-
sels were found in the subcutaneous tissues ofthe feet,
adjacent to tendons and within the synovium (Figures
3 and 4). No vessels in other tissues contained carbon
particles and none of the venules in the control rats
were labeled. The rats killed 6 hours after intravenous
PS had no degranulating mast cells and none of their
vessels were labeled by carbon particles injected 30
minutes before sacrifice. The 6-hour PBS controls ap-
peared the same.
Effect of Compound 48/80 on PS-Induced Edema
There were 3 experimental groups (Table 1). In
Group 1 6 rats were pretreated with 48/80, injected
Table 1 -Compound 48/80 Inhibition of Polysaccharide-
Induced Edema
Evans blue dye content
Experimental groups in both right feet
Six rats given 48/80 IP for 5 days, 19.1 ± 3.2 gg
day 6 Evans blue 6.5 mg IV 45' and (range, 17-25)
PBS IV 30' before sacrifice
11
Seven rats given 48/80 IP for 5 days, 19.5 ± 2.4 Ag
day 6 Evans blue 6.5 mg IV 45' and (range, 16-24)
PS IV 30' before sacrifice.
Illl
Seven rats given PBS IP for 5 days, 164 ± 106 gg
day 6 Evans blue 6.5 mg IV 45' and (range, 36-322)
PS IV 30' before sacrifice.
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Figure 5-Effect of pretreatment with 48/80
upon PS-induced edema. Both rats were in-
jected intravenously with Evans blue 45 minutes
and PS 30 minutes before they were killed. The
rat in A had been pretreated with 48/80 and had
no edema or excess blueing of any tissues. The
rat in B was not pretreated with 48/80 and
quickly developed swollen, blue feet. In addition
there was blueing of the nose and the bases of
both ears.
with Evans blue and then PBS, and killed after 30 min-
utes. There was no evidence ofedema or increased blue-
ing in any tissues. Histologic sections ofthe left feet were
free of toluidine blue staining mast cells except in the
perineurium of peripheral nerves where they remained
8intact. The right feet contained a total of 19.1 ± 3.2 ,ug
Evans blue with a range of 17.2-25.0 ,ug. In Group II 7
rats were pretreated with 48/80, injected first with Evans
blue and then with 6 ,ug PS/g body weight 30 minutes
before they were killed. None of the rats developed
edema and none had increased blueing of any tissues.
Histologic sections ofthe left feet were again free ofgran-
ulated mast cells except those associated with nerves,
and none showed morphologic evidence of granule re-
lease. The right feet contained a total of 19.5 ± 2.4 tg
Evans blue with a range of 16.0-23.7 jig. In Group III 7
rats that were not treated with 48/80 were injected with
Evans blue and then 6 ug PS/g body weight 30 minutes
before they were killed. Six rats developed edema (± to
4+) together with deep blueing ofall 4 feet and 4 ofthese
6 rats also had blueing oftheir ears (Figure 5). Histologi-
cally many mast cells in the left feet had released their
granules and the right feet contained 164.2 ± 106.0 ,g
Evans blue with a range of 36.7-322.2 ,ug.
Effect of 48/80 on PG-PS-Induced Arthritis
The clinical evaluation of the arthritis, shown in
Figure 6, indicates that the 48/80 pretreatment had
AJP * August 1988
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only slight effect on the arthritis. Half the rats in both
groups were killed 3 days after PG-PS injection and
the rest were observed and finally killed on day 40.
The total PG/PS content ofthe right feet ofthe Group
1 rats sacrificed acutely on day 3, 3 days after PG-PS
injection, was 2.06 ,ug (±3.03 Mg). The PG-PS content
of the right feet of the 48/80 pretreated Group 2 rats
killed acutely on day 3 was 1.03 ,ug (± 1.17 ,g). The
PG-PS content of the right feet of Group 1 rats sacri-
ficed on day 40 was 0.43 ,ug (±0.41 ug) and that of
Group 2 was 0.54 ,g (±0.54 Mug). None of these differ-
ences was statistically significant.
Discussion
The data presented here support the conclusion
that purified Group A streptococcal PS causes acute
edema in the feet ofSprague-Dawley rats by stimulat-
ing the local mast cells to release their granules, result-
ing in increased microvascular permeability and
edema. This conclusion is consistent with the acute,
transient course ofthe reaction,'0 the morphologic ap-
pearance ofthe mast cells, the labeling ofthe adjacent
venules with injected carbon particles, and the block-
ing of the reaction by the pretreatment with com-
pound 48/80. Thus, group A streptococcal PS can
probably be added to the growing list of microbial
products that cause nonimmune mast cell activation,
such as yeast cell wall polysaccharides,"I staphylococ-
cal cell wall sugars,'2 E. coli alpha hemolysin,'3 and
staphylococcal enterotoxin B. 14-16
The presence of large numbers of mast cells in the
feet ofrats and the selective granule release by purified
PS suggested that this early increase in vascular per-
meability might be the initial reaction responsible for
the selective articular deposition of systemically in-
jected PG-PS, because these preparations of cell wall
fragments also contain some free PS. However, the de-
granulation ofmast cells with compound 48/80, which
blocked the PS-induced acute edema, did not prevent
either the deposition of PG-PS in the joints or the de-
velopment of arthritis. Moreover, toluidine blue stains
of the joints of rats injected intraperineally with an ar-
thropathic dose ofPG-PS from an earlier study2 failed
to reveal any evidence of mast cell release during the
early hours after injection. Another explanation for the
selective deposition ofPG-PS in experimental arthritis
probably lies in a related observation from this labora-
tory. When PG-PS polymer from group A streptococci
is solubilized by M-1 mutanolysin it is no longer ar-
thropathic, but these small molecular weight fragments
ofPG-PS will induce paw edema when injected either
intravenously4 or directly into joints. 7 However, this
48/80 and PG-PS ARTHRITIS
2
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Figure 6-The effect of pretreatment with 48/80 upon PG-PS induced ar-
thritis. The open circles are the total mean joint scores for Group 1 control
rats receiving only saline (PBS) before PG-PS and the solid circles represent
the total mean scores for the Group 2 rats that were pretreated for 5 days
with compound 48/80. The bars are the standard deviations.
reaction persists for as long as 12 hours.4 The increased
permeability caused by soluble PG-PS is thus an im-
mediate-prolonged reaction,10 suggesting that it is due
to endothelial injury, direct or indirect, not mediated
by local histamine release. A preliminary study of
edema induced by small molecular weight (mutano-
lysin degraded) PG-PS, demonstrated carbon labeling
of articular venules without morphologic evidence of
mast cell release. Because the sonicated PG-PS prepa-
rations also contain some small molecular weight PG-
PS, it is hypothesized that the systemic injection of
these small fragments in these preparations causes the
initial vascular injury that then leads to the articular
localization ofthe larger arthropathic fragments. Thus,
both free PS and small PG-PS polymers can increase
vascular permeability and contribute to the localiza-
tion of arthropathic PG-PS in the limbs, but only the
PS functions through mast cell degranulation. Just why
the vascular bed of the distal joints in the rat is more
sensitive to this injury is not yet understood, but there
are other examples of the selective effects of systemi-
cally injected bacterial products on specific vascular
beds. 18-20
In another context, the degranulation of mast cells
by streptococcal PS might explain why bacteremia in
humans can result in infectious arthritis.2' Many
other bacteria probably produce constituents capable
ofactivating mast cells and because human joints con-
tain large numbers of these cells,22 degranulation and
transient vascular leakage could be involved in the
pathogenesis of articular infections.
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